The components of the cholinergic system are evolutionary very old and conserved molecules that are expressed in typical spatiotemporal patterns. They are involved in signaling in the nervous system, whereas their functions in nonneuronal tissues are hardly understood. Stem cells present an attractive cellular system to address functional issues. This study therefore compared human induced pluripotent stem cells (iPSCs; from cord blood endothelial cells), mesenchymal stromal cells derived from iPSCs (iPSC-MSCs), and bone marrow-derived MSCs (BM-MSCs) from up to 33 different human donors with respect to gene expressions of components of the cholinergic system. The status of cells was identified and characterized by the detection of cell surface antigens using flow cytometry. Acetylcholinesterase expression in iPSCs declined during their differentiation into MSCs and was comparably low in BM-MSCs. Butyrylcholinesterase was present in iPSCs, increased upon transition from the three-dimensional embryoid body phase into monolayer culture, and declined upon further differentiation into iPSC-MSCs. In BM-MSCs a notable butyrylcholinesterase expression could be detected in only four donors, but was elusive in other patient-derived samples. Different nicotinic acetylcholine receptor subunits were preferentially expressed in iPSCs and during early differentiation into iPSC-MSCs, low expression was detected in iPS-MSCs and in BM-MSCs. The m2 and m3 variants of muscarinic acetylcholine receptors were detected in all stem cell populations. In BM-MSCs, these gene expressions varied between donors. Together, these data reveal the differential expression of cholinergic signaling system components in stem cells from specific sources and suggest the utility of our approach to establish informative biomarkers.
Get full access to this article
View all access options for this article.
References
1.
AmaroliA, GallusL, PassalacquaM, FalugiC, ViarengoA and Delmonte CorradoMU. (2003). Detection of cholinesterase activities and acetylcholine receptors during the developmental cycle of Dictyostelium discoideum. Eur J Protistol, 39:213–222.
2.
HoriuchiY, KimuraR, KatoN, FujiiT, SekiM, EndoT, KatoT and KawashimaK. (2003). Evolutional study on acetylcholine expression. Life Sci, 72:1745–1756.
3.
RaineriM and ModenesiP. (1986). Preliminary evidence for a cholinergic-like system in lichen morphogenesis. Histochem J, 18:647–657.
4.
SaganeY, NakagawaT, YamamotoK, MichikawaS, OguriS and MomonokiYS. (2005). Molecular characterization of maize acetylcholinesterase: a novel enzyme family in the plant kingdom. Plant Physiol, 138:1359–1371.
5.
Delmonte CorradoMU, PolitiH, OgnibeneM, AngeliniC, TrielliF, BallariniP and FalugiC. (2001). Synthesis of the signal molecule acetylcholine during the developmental cycle of Paramecium primaurelia (Protista, Ciliophora) and its possible function in conjugation. J Exp Biol, 204:1901–1907.
6.
SoreqH, MalingerG and ZakutH. (1987). Expression of cholinesterase genes in human oocytes revealed by in-situ hybridization. Hum Reprod, 2:689–693.
DrewsU. (1975). Cholinesterase in embryonic development. Prog Histochem Cytochem, 7:1–52.
9.
BuznikovGA, ShmuklerYB and LauderJM. (1996). From oocyte to neuron: do neurotransmitters function in the same way throughout development?. Cell Mol Neurobiol, 16:537–559.
10.
WesslerI, KirkpatrickCJ and RackéK. (1999). The cholinergic ‘pitfall’: acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol, 26:198–205.
11.
WesslerIK and KirkpatrickCJ. (2001). The non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol Ther, 14:423–434.
12.
WesslerI, KilbingerH, BittingerF, UngerR and KirkpatrickCJ. (2003). The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci, 72:2055–2061.
13.
KarczmarAG. (2010). Cholinesterases (ChEs) and the cholinergic system in ontogenesis and phylogenesis, and non-classical roles of cholinesterases - a review. Chem Biol Interact, 187:34–43.
14.
LandgrafD, BarthM, LayerPG and SperlingLE. (2010). Acetylcholine as a possible signaling molecule in embryonic stem cells: studies on survival, proliferation and death. Chem Biol Interact, 187:115–119.
15.
Vogel-HöpkerA, SperlingLE and LayerPG. (2012). Co-opting functions of cholinesterases in neural, limb and stem cell development. Protein Pept Lett, 19:155–164.
16.
BoopathyR and LayerPG. (2004). Aryl acylamidase activity on acetylcholinesterase is high during early chicken brain development. Protein J, 23:325–333.
17.
LayerPG, AllebrandtK, AndermannP, BodurE, BoopathyR, BytyqiAH and ParaoanuLE. (2005). On the multifunctionality of cholinesterases. Chem Biol Interact, 157–158:37–41.
18.
SharmaKV, KoenigsbergerC, BrimijoinS and BigbeeJW. (2001). Direct evidence for an adhesive function in the noncholinergic role of acetylcholinesterase in neurite outgrowth. J Neurosci Res, 63:165–175.
19.
MassouliéJ, BonS and VignyM. (1980). The polymorphism of cholinesterase in vertebrates. Neurochem Int, 2C:161–184.
20.
MeshorerE, ErbC, GazitR, PavlovskyL, KauferD, FriedmanA, GlickD, Ben-ArieN and SoreqH. (2002). Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science, 295:508–512.
21.
ZhangXJ, YangL, ZhaoQ, CaenJP, HeHY, JinQH, GuoLH, AlemanyM, ZhangLY and ShiYF. (2002). Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death Differ, 9:790–800.
22.
GeneverPG, BirchMA, BrownE and SkerryTM. (1999). Osteoblast-derived acetylcholinesterase: a novel mediator of cell-matrix interactions in bone?. Bone, 24:297–303.
23.
LockridgeO. (1988). Structure of human serum cholinesterase. BioEssays, 9:125–128.
24.
LayerPG. (1983). Comparative localization of acetylcholinesterase and pseudocholinesterase during morphogenesis of the chicken brain. Proc Natl Acad Sci U S A, 80:6413–6417.
25.
LayerPG and SpornsO. (1987). Spatiotemporal relationship of embryonic cholinesterases with cell proliferation in chicken brain and eye. Proc Natl Acad Sci U S A, 84:284–288.
26.
WeikertT, RathjenFG and LayerPG. (1990). Developmental maps of acetylcholinesterase and G4-antigen of the early chicken brain: long-distance tracts originate from AChE-producing cell bodies. J Neurobiol, 21:482–498.
27.
LayerPG, AlberR and RathjenFG. (1988). Sequential activation of butyrylcholinesterase in rostral half somites and acetylcholinesterase in motoneurones and myotomes preceding growth of motor axons. Development, 102:387–396.
28.
SperlingLE, SteinertG, BoutterJ, LandgrafD, HeschelerJ, PolletD and LayerPG. (2008). Characterisation of cholinesterase expression during murine embryonic stem cell differentiation. Chem Biol Interact, 175:156–160.
29.
KaltwasserS, SchmitzL, Michel-SchmidtR, AnspachL, KirkpatrickCJ and WesslerI. (2015). Murine embryonic stem cell line CGR8 expresses all subtypes of muscarinic receptors and multiple nicotinic receptor subunits: down-regulation of alpha4- and beta4-subunits during early differentiation. Int Immunopharmacol, 29:110–114.
30.
HoogduijnMJ, ChengA and GeneverPG. (2009). Functional nicotinic and muscarinic receptors on mesenchymal stem cells. Stem Cells Dev, 18:103–112.
31.
SpiekerJ, MudersbachT, Vogel-HöpkerA and LayerPG. (2017). Endochondral ossification is accelerated in cholinesterase-deficient mice and in avian mesenchymal micromass cultures. PLoS One, 12:e0170252.
32.
GrisaruD, SternfeldM, EldorA, GlickD and SoreqH. (1999). Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem, 264:672–686.
33.
LayerPG, KlaczinskiJ, SalfelderA, SperlingLE, ThangarajG, TuschlC and Vogel-HöpkerA. (2013). Cholinesterases in development: AChE as a firewall to inhibit cell proliferation and support differentiation. Chem Biol Interact, 203:269–276.
34.
MafiP, HindochaS, MafiR, GriffinM and KhanWS. (2011). Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature. Open Orthop J, 5:253–260.
35.
BernardoME and FibbeWE. (2013). Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell, 13:392–402.
36.
RenG, SuJ, ZhangL, ZhaoX, LingW, L'HuillieA, ZhangJ, LuY, RobertsAI, et al. (2009). Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells, 27:1954–1962.
ZukPA, ZhuM, AshjianP, De UgarteDA, HuangJI, MizunoH, AlfonsoZC, FraserJK, BenhaimP and HedrickMH. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell, 13:4279–4295.
39.
FriedensteinAJ, PetrakovaKV, KurolesovaAI and FrolovaGP. (1968). Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, 6:230–247.
40.
GronthosS, MankaniM, BrahimJ, RobeyPG and ShiS. (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A, 97:13625–13630.
41.
TroyerDL and WeissML. (2008). Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells, 26:591–599.
42.
RogersI and CasperRF. (2004). Umbilical cord blood stem cells. Best Pract Res Clin Obstet Gynaecol, 18:893–908.
43.
PittengerMF, MackayAM, BeckSC, JaiswalRK, DouglasR, MoscaJD, MoormanMA, SimonettiDW, CraigS and MarshakDR. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284:143–147.
44.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
45.
HaaseA, OlmerR, SchwankeK, WunderlichS, MerkertS, HessC, ZweigerdtR, GruhI, MeyerJ, et al. (2009). Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell, 5:434–441.
46.
KempfH, OlmerR, KroppC, RückertM, Jara-AvacaM, Robles-DiazD, FrankeA, ElliottDA, WojciechowskiD, et al. (2014). Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture. Stem Cell Reports, 3:1132–1146.
47.
LeeEJ, LeeHN, KangHJ, KimKH, HurJ, ChoHJ, LeeJ, ChungHM, ChoJ, et al. (2010). Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. Tissue Eng Part A, 16:705–715.
48.
KurosawaH. (2007). Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. J Biosci Bioeng, 103:389–398.
49.
LianQ, ZhangY, ZhangJ, ZhangHK, WuX, ZhangY, LamFF, KangS, XiaJC, et al. (2010). Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation, 121:1113–1123.
50.
LaiRC, ChooA and LimSK. (2011). Derivation and characterization of human ESC-derived mesenchymal stem cells. Methods Mol Biol, 698:141–150.
51.
GuzzoRM, GibsonJ, XuRH, LeeFY and DrissiH. (2013). Efficient differentiation of human iPSC-derived mesenchymal stem cells to chondroprogenitor cells. J Cell Biochem, 114:480–490.
52.
DiederichsS and TuanRS. (2014). Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. Stem Cells Dev, 23:1594–1610.
53.
HwangNS, VargheseS, LeeHJ, ZhangZ, YeZ, BaeJ, ChengL and ElisseeffJ. (2008). In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A, 105:20641–20646.
54.
LiuJ, ChenW, ZhaoZ and XuHH. (2013). Reprogramming of mesenchymal stem cells derived from iPSCs seeded on biofunctionalized calcium phosphate scaffold for bone engineering. Biomaterials, 34:7862–7872.
55.
GruenlohW, KambalA, SondergaardC, McGeeJ, NaceyC, KalomoirisS, PepperK, OlsonS, FierroF and NoltaJA. (2011). Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Eng Part A, 17:1517–1525.
56.
LianQ, LyeE, Suan YeoK, Khia Way TanE, Salto-TellezM, LiuTM, PalanisamyN, El OakleyRM, LeeEH, LimB and LimSK. (2007). Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells, 25:425–436.
57.
BrownSE, TongW and KrebsbachPH. (2009). The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs, 189:256–260.
58.
KarlssonC, EmanuelssonK, WessbergF, KajicK, AxellMZ, ErikssonPS, LindahlA, HyllnerJ and StrehlR. (2009). Human embryonic stem cell-derived mesenchymal progenitors—potential in regenerative medicine. Stem Cell Res, 3:39–50.
59.
HynesK, MenicaninD, MrozikK, GronthosS and BartoldPM. (2014). Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines. Stem Cells Dev, 23:1084–1096.
60.
GiulianiM, OudrhiriN, NomanZM, VernochetA, ChouaibS, AzzaroneB, DurrbachA and Bennaceur-GriscelliA. (2011). Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. Blood, 118:3254–3262.
61.
ZhaoQ, GregoryCA, LeeRH, RegerRL, QinL, HaiB, ParkMS, YoonN, CloughB, et al. (2015). MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs. Proc Natl Acad Sci U S A, 112:530–535.
62.
PoloJM, LiuS, FigueroaME, KulalertW, EminliS, TanKY, ApostolouE, StadtfeldM, LiY, et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol, 28:848–855.
63.
BurrowsCK, BanovichNE, PavlovicBJ, PattersonK, Gallego RomeroI, PritchardJK and GiladY. (2016). Genetic variation, not cell type of origin, underlies the majority of identifiable regulatory differences in iPSCs. PLoS Genet, 12:e1005793.
64.
de AlmeidaDC, FerreiraMR, FranzenJ, WeidnerCI, FrobelJ, ZenkeM, CostaIG and WagnerW. (2016). Epigenetic classification of human mesenchymal stromal cells. Stem Cell Reports, 6:168–175.
65.
ReinischA, EtchartN, ThomasD, HofmannNA, FruehwirthM, SinhaS, ChanCK, Senarath-YapaK, SeoE-Y, et al. (2015). Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. Blood, 125:249–260.
66.
BoschJ, HoubenAP, RadkeTF, StapelkampD, BünemannE, BalanP, BuchheiserA, LiedtkeS and KöglerG. (2012). Distinct differentiation potential of “MSC” derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells?. Stem Cells Dev, 21:1977–1988.
67.
PicchiJ, TrombiL, SpugnesiL, BarachiniS, MaroniG, BrodanoGB, BorianiS, ValtieriM, PetriniM and MagliMC. (2013). HOX and TALE signatures specify human stromal stem cell populations from different sources. J Cell Physiol, 228:879–889.
68.
SchäckLM, NoackS, WinklerR, WissmannG, BehrensP, WellmannM, JagodzinskiM, KrettekC and HoffmannA. (2013). The phosphate source influences gene expression and quality of mineralization during osteogenic differentiation of human mesenchymal stem cells. PLoS One, 8:e65943.
69.
DominiciM, Le BlancK, MuellerI, Slaper-CortenbachI, MariniF, KrauseD, DeansR, KeatingA, ProckopD and HorwitzE. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:315–317.
70.
RamirezJM, Gerbal-ChaloinS, MilhavetO, QiangB, BeckerF, AssouS, LemaitreJM, HamamahS and De VosJ. (2011). Brief report: benchmarking human pluripotent stem cell markers during differentiation into the three germ layers unveils a striking heterogeneity: all markers are not equal. Stem Cells, 29:1469–1474.
71.
SchäckLM, NoackS, WeistR, JagodzinskiM, KrettekC, BuettnerM and HoffmannA. (2013). Analysis of surface protein expression in human bone marrow stromal cells: new aspects of culture-induced changes, inter-donor differences and intracellular expression. Stem Cells Dev, 22:3226–3235.
72.
GangEJ, BosnakovskiD, FigueiredoCA, VisserJW and PerlingeiroRC. (2007). SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood, 109:1743–1751.
73.
Rosu-MylesM, McCullyJ, FairJ, MehicJ, MenendezP, RodriguezR and WestwoodC. (2013). The globoseries glycosphingolipid SSEA-4 is a marker of bone marrow-derived clonal multipotent stromal cells in vitro and in vivo. Stem Cells Dev, 22:1387–1397.
74.
BarberiT, WillisLM, SocciND and StuderL. (2005). Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med, 2:e161.
75.
OlivierEN, RybickiAC and BouhassiraEE. (2006). Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells, 24:1914–1922.
76.
LvFJ, TuanRS, CheungKM and LeungVY. (2014). Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells, 32:1408–1419.
77.
ParaoanuLE, SteinertG, KoehlerA, WesslerI and LayerPG. (2007). Expression and possible functions of the cholinergic system in a murine embryonic stem cell line. Life Sci, 80:2375–2379.
78.
WillboldE and LayerPG. (1994). Butyrylcholinesterase regulates laminar retinogenesis of the chick embryo in vitro. Eur J Cell Biol, 64:192–199.
79.
ZimmermanG and HSoreq. (2006). Readthrough acetylcholinesterase: a multifaceted inducer of stress reactions. J Mol Neurosci, 30:197–200.
80.
DeutschVR, PickM, PerryC, GrisaruD, HemoY, Golan-HadariD, GrantA, and EldorA and SoreqH. (2002). The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. Exp Hematol, 30:1153–1161.
81.
GrisaruD, Lev-LehmanE, ShapiraM, ChaikinE, LessingJB, EldorA, EcksteinF and SoreqH. (1999). Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3’ alternative splicing variant of acetylcholinesterase. Mol Cell Biol, 19:788–795.
82.
WangH, YuM, OchaniM, AmellaCA, TanovicM, SusarlaS, LiJH, WangH, YangH, et al. (2003). Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature, 421:384–388.
83.
AtluriP, FleckMW, ShenQ, MahSJ, StadfeltD, BarnesW, GoderieSK, TempleS and SchneiderAS. (2001). Functional nicotinic acetylcholine receptor expression in stem and progenitor cells of the early embryonic mouse cerebral cortex. Dev Biol, 240:143–156.
84.
EgletonRD, BrownKC and PDasgupta. (2008). Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci, 29:151–158.
85.
LinW, HirataN, SekinoY and Kanda YY. Role of α7-nicotinic acetylcholine receptor in normal and cancer stem cells. Curr Drug Targets, 13:656–665.
86.
RenC, TongYL, LiJC, LuZQ and YaoYM. (2017) The protective effect of alpha 7 nicotinic acetylcholine receptor activation on critical illness and its mechanism. Int J Biol Sci, 13:46–56.
87.
MitoK, SatoY, KobayashiT, MiyamotoK, NittaE, IwamaA, MatsumotoM, NakamuraM, SatoK and MiyamotoT. (2017). The nicotinic acetylcholine receptor α7 subunit is an essential negative regulator of bone mass. Sci Rep, 7:45597.
88.
AlberR, SpornsO, WeikertT, WillboldE and LayerPG. (1994). Cholinesterases and peanut agglutinin binding related to cell proliferation and axonal growth in embryonic chick limbs. Anat Embryol (Berl), 190:429–438.
89.
SpiekerJ, AckermannA, SalfelderA, Vogel-HöpkerA and LayerPG. (2016). Acetylcholinesterase regulates skeletal in ovo development of chicken limbs by ACh-dependent and -independent mechanisms. PLoS One, 11:e0161675.
90.
LancasterMA, RennerM, MartinCA, WenzelD, BicknellLS, HurlesME, HomfrayT, PenningerJM, JacksonAP, and KnoblichJA. (2013). Cerebral organoids model human brain development and microcephaly. Nature, 501:373–379.
91.
EldredMK, Charlton-PerkinsM, MuresanL., and HarrisWA. (2017). Self-organising aggregates of zebrafish retinal cells for investigating mechanisms of neural lamination. Development, 144:1097–1106.
92.
SimianM and BissellMJ. 2017. Organoids: a historical perspective of thinking in three dimensions. J Cell Biol, 216:31–40.
93.
LayerPG. (2017). Humane Organoide: Ein biomedizinischer Durchbruch mit neuen Zellen und alter Technik. Biol Unserer Zeit, 47:312–318.
94.
SchaafCP. (2014). Nicotinic acetylcholine receptors in human genetic disease. Genet Med, 16:649–656.
95.
SaidHM, HagemannC, StojicJ, SchoemigB, VinceGH, FlentjeM, RoosenK and VordermarkD. (2007). GAPDH is not regulated in human glioblastoma under hypoxic conditions. BMC Mol Biol, 8:55.
96.
Gomez-EsquerF, AgudoD, Martinez-ArribasF, Nunez-VillarMJ and SchneiderJ. (2004). mRNA expression of the angiogenesis markers VEGF and CD105 (endoglin) in human breast cancer. Anticancer Res, 24:1581–1585.
97.
KarpelR, Ben Aziz-AloyaR, SternfeldM, EhrlichG, GinzbergD, TarroniP, ClementiF, ZakutH and SoreqH. (1994). Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins. Exp Cell Res, 210:268–277.
98.
PapariniD, GoriS, GrassoE, ScordoW, CaloG, Perez LeirosC, RamhorstR and SalamoneG. (2015). Acetylcholine contributes to control the physiological inflammatory response during the peri-implantation period. Acta Physiol (Oxf), 214:237–247.
99.
LipsKS, WunschJ, ZarghooniS, BschleipferT, SchukowskiK, WeidnerW, WesslerI, SchwantesU, KoepsellH and KummerW. (2007). Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. Eur Urol, 51:1042–1053.
100.
NdoyeA, BuchliR, GreenbergB, NguyenVT, ZiaS, RodriguezJG, WebberRJ, LawryMA and GrandoSA. (1998). Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis. J Invest Dermatol, 111:410–416.
101.
LiQ, ZhouX, KolosovVP and PerelmanJM. (2012). The expression and pharmacological characterization of nicotinic acetylcholine receptor subunits in HBE16 airway epithelial cells. Cell Biochem Biophys, 62:421–431.
102.
Hellstrom-LindahlE, GorbounovaO, SeigerA, MousaviM and NordbergA. (1998). Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord. Brain Res Dev Brain Res, 108:147–160.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
